Cabaletta Bio IncNASDAQ:CABA
- LAST PRICE4.1850
- TODAY'S CHANGE (%)0.1850 (4.6250%)
- Bid / Lots4.1800/ 7
- Ask / Lots4.1900/ 3
- Open / Previous Close3.9900 / 4.0000
- Day Range
- 52 Week Range
- Volume402,681
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CABA |
|---|---|---|
| 09:32 ET | 3917 | 4.005 |
| 09:33 ET | 2350 | 4.06 |
| 09:35 ET | 200 | 4.045 |
| 09:37 ET | 1100 | 4.03 |
| 09:39 ET | 801 | 4.01 |
| 09:42 ET | 112 | 4.06 |
| 09:44 ET | 1200 | 4.03 |
| 09:46 ET | 2191 | 4.02 |
| 09:48 ET | 2700 | 3.99 |
| 09:50 ET | 200 | 4 |
| 09:51 ET | 701 | 4.02 |
| 09:53 ET | 1600 | 4.04 |
| 09:55 ET | 266 | 4.04 |
| 09:57 ET | 1700 | 4.01 |
| 10:00 ET | 4180 | 4.02 |
| 10:02 ET | 2029 | 3.99 |
| 10:04 ET | 1297 | 4.01 |
| 10:06 ET | 1300 | 4.04 |
| 10:08 ET | 700 | 4.06 |
| 10:09 ET | 2012 | 4.05 |
| 10:11 ET | 2951 | 4.06 |
| 10:13 ET | 1250 | 4.06 |
| 10:15 ET | 700 | 4.04 |
| 10:18 ET | 4510 | 4 |
| 10:20 ET | 600 | 4 |
| 10:24 ET | 4052 | 3.98 |
| 10:26 ET | 616 | 3.99 |
| 10:27 ET | 15975 | 3.9883 |
| 10:29 ET | 500 | 3.99 |
| 10:31 ET | 8623 | 4.005 |
| 10:33 ET | 1100 | 4.005 |
| 10:36 ET | 3284 | 3.985 |
| 10:38 ET | 360 | 3.99 |
| 10:40 ET | 200 | 4.015 |
| 10:42 ET | 940 | 4.0236 |
| 10:44 ET | 517 | 4.06 |
| 10:45 ET | 2471 | 4.07 |
| 10:47 ET | 1515 | 4.08 |
| 10:49 ET | 715 | 4.085 |
| 10:51 ET | 100 | 4.09 |
| 10:54 ET | 300 | 4.09 |
| 10:56 ET | 1556 | 4.075 |
| 10:58 ET | 2033 | 4.07 |
| 11:03 ET | 1539 | 4.065 |
| 11:05 ET | 2637 | 4.08 |
| 11:07 ET | 100 | 4.09 |
| 11:09 ET | 335 | 4.085 |
| 11:12 ET | 200 | 4.085 |
| 11:14 ET | 2600 | 4.085 |
| 11:16 ET | 500 | 4.085 |
| 11:18 ET | 408 | 4.0812 |
| 11:20 ET | 1681 | 4.075 |
| 11:21 ET | 1486 | 4.08 |
| 11:23 ET | 500 | 4.09 |
| 11:25 ET | 800 | 4.1 |
| 11:27 ET | 765 | 4.1009 |
| 11:30 ET | 7732 | 4.105 |
| 11:32 ET | 803 | 4.11 |
| 11:34 ET | 700 | 4.115 |
| 11:36 ET | 581 | 4.125 |
| 11:38 ET | 3102 | 4.135 |
| 11:39 ET | 400 | 4.14 |
| 11:41 ET | 1029 | 4.13 |
| 11:43 ET | 2600 | 4.125 |
| 11:45 ET | 1100 | 4.125 |
| 11:48 ET | 600 | 4.125 |
| 11:50 ET | 1250 | 4.125 |
| 11:52 ET | 8014 | 4.12 |
| 11:54 ET | 400 | 4.13 |
| 11:57 ET | 1475 | 4.13 |
| 11:59 ET | 1000 | 4.12 |
| 12:01 ET | 1482 | 4.095 |
| 12:03 ET | 600 | 4.095 |
| 12:06 ET | 673 | 4.11 |
| 12:08 ET | 1200 | 4.135 |
| 12:10 ET | 300 | 4.135 |
| 12:12 ET | 1717 | 4.12 |
| 12:14 ET | 300 | 4.14 |
| 12:15 ET | 100 | 4.14 |
| 12:17 ET | 400 | 4.135 |
| 12:19 ET | 100 | 4.14 |
| 12:21 ET | 100 | 4.14 |
| 12:24 ET | 116 | 4.14 |
| 12:26 ET | 400 | 4.135 |
| 12:28 ET | 378 | 4.135 |
| 12:30 ET | 500 | 4.145 |
| 12:32 ET | 100 | 4.15 |
| 12:33 ET | 2081 | 4.135 |
| 12:37 ET | 1250 | 4.125 |
| 12:39 ET | 633 | 4.13 |
| 12:44 ET | 100 | 4.14 |
| 12:46 ET | 1099 | 4.135 |
| 12:51 ET | 400 | 4.1316 |
| 12:53 ET | 200 | 4.1342 |
| 12:55 ET | 1646 | 4.125 |
| 12:57 ET | 200 | 4.12 |
| 01:00 ET | 300 | 4.14 |
| 01:02 ET | 2496 | 4.1401 |
| 01:04 ET | 596 | 4.14 |
| 01:06 ET | 100 | 4.135 |
| 01:11 ET | 980 | 4.135 |
| 01:13 ET | 2043 | 4.13 |
| 01:15 ET | 100 | 4.135 |
| 01:18 ET | 662 | 4.14 |
| 01:22 ET | 300 | 4.145 |
| 01:24 ET | 200 | 4.145 |
| 01:26 ET | 2300 | 4.145 |
| 01:27 ET | 1911 | 4.155 |
| 01:29 ET | 4171 | 4.145 |
| 01:31 ET | 2151 | 4.13 |
| 01:33 ET | 100 | 4.125 |
| 01:38 ET | 2100 | 4.12 |
| 01:40 ET | 1560 | 4.115 |
| 01:42 ET | 665 | 4.115 |
| 01:44 ET | 766 | 4.13 |
| 01:45 ET | 646 | 4.135 |
| 01:47 ET | 500 | 4.135 |
| 01:51 ET | 200 | 4.135 |
| 01:54 ET | 3557 | 4.145 |
| 01:56 ET | 400 | 4.15 |
| 01:58 ET | 1000 | 4.145 |
| 02:00 ET | 54905 | 4.105 |
| 02:02 ET | 3619 | 4.0999 |
| 02:03 ET | 3616 | 4.13 |
| 02:05 ET | 882 | 4.12 |
| 02:07 ET | 174 | 4.1105 |
| 02:09 ET | 1575 | 4.106791 |
| 02:14 ET | 1358 | 4.1 |
| 02:16 ET | 100 | 4.105 |
| 02:18 ET | 1794 | 4.105 |
| 02:23 ET | 1380 | 4.1 |
| 02:25 ET | 496 | 4.115 |
| 02:32 ET | 1900 | 4.105 |
| 02:34 ET | 1302 | 4.11 |
| 02:36 ET | 323 | 4.115 |
| 02:38 ET | 100 | 4.11 |
| 02:39 ET | 2600 | 4.11 |
| 02:41 ET | 1365 | 4.12 |
| 02:45 ET | 2648 | 4.125 |
| 02:48 ET | 4612 | 4.14 |
| 02:50 ET | 1404 | 4.145 |
| 02:52 ET | 4411 | 4.15 |
| 02:54 ET | 1724 | 4.17 |
| 02:56 ET | 1345 | 4.165 |
| 02:57 ET | 5543 | 4.15 |
| 02:59 ET | 342 | 4.1412 |
| 03:01 ET | 1630 | 4.14 |
| 03:03 ET | 500 | 4.145 |
| 03:06 ET | 500 | 4.145 |
| 03:08 ET | 921 | 4.155 |
| 03:10 ET | 500 | 4.16 |
| 03:12 ET | 2069 | 4.16 |
| 03:14 ET | 600 | 4.16 |
| 03:15 ET | 600 | 4.16 |
| 03:17 ET | 100 | 4.16 |
| 03:19 ET | 4140 | 4.16 |
| 03:21 ET | 500 | 4.15 |
| 03:24 ET | 1900 | 4.15 |
| 03:26 ET | 6387 | 4.185 |
| 03:28 ET | 5298 | 4.185 |
| 03:30 ET | 200 | 4.185 |
| 03:32 ET | 2687 | 4.195 |
| 03:33 ET | 1400 | 4.1916 |
| 03:35 ET | 1300 | 4.1924 |
| 03:37 ET | 3286 | 4.2 |
| 03:39 ET | 5913 | 4.2 |
| 03:42 ET | 9179 | 4.2 |
| 03:44 ET | 1300 | 4.185 |
Oct 10, 2024
DJ Cabaletta Bio Initiated at Buy by UBS, from 9:39AM ET on Thursday Oct 10, 2024 by Dow Jones
9:39AM ET on Thursday Oct 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cabaletta Bio Inc | 195.4M | -2.2x | --- |
Gossamer Bio Inc | 200.5M | -2.2x | --- |
Tenaya Therapeutics Inc | 190.1M | -1.4x | --- |
DiaMedica Therapeutics Inc | 189.4M | -8.4x | --- |
Kodiak Sciences Inc | 205.2M | -1.1x | --- |
Instil Bio Inc | 179.7M | -1.5x | --- |
Company Information
Cabaletta Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on the discovery and development of engineered T cell therapies that have the potential to provide deep and durable, perhaps curative, responses with one-time administration for patients with autoimmune diseases. Its Cabaletta Approach to B cell Ablation (CABA) platform encompasses two strategies: Chimeric Antigen Receptor T cells for Autoimmunity (CARTA) and Chimeric AutoAntibody Receptor T cells (CAART). CABA-201, its lead product candidate from its CARTA platform, is a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T construct designed to treat patients with a range of autoimmune diseases. Its DSG3-CAART product candidate is being evaluated for the treatment of mPV, a subtype of PV that affects the epithelium of the mucous membranes, in the Phase 1 DesCAARTes TM trial. Its MuSK-CAART product candidate is designed to treat a subset of patients with MG, targeting autoreactive B cells.
Contact Information
- Headquarters
- 2929 Arch Street, Suite 600PHILADELPHIA, PA, United States 19104
- Phone
- 267-759-3100
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer, Co-Founder
- Steven Nichtberger
- Chief Financial Officer
- Anup Marda
- President - Science and Technology
- Gwendolyn Binder-Scholl
- General Counsel, Secretary
- Michael Gerard
- Chief Medical Officer
- David Chang
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $195.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 48.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.38 |
EPS | $-1.92 |
Book Value | $4.94 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
